A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This phase II clinical study is designed to evaluate the efficacy and safety of LT3001 inthe treatment of acute ischemic stroke
Epistemonikos ID: 5f5982a417ce8f9d3a8be83bff91d94c71671aa0
First added on: Aug 11, 2026